Page last updated: 2024-08-21

butyramide and Breast Neoplasms

butyramide has been researched along with Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jedinak, A; Jiang, J; Krchňák, V; Sandusky, GE; Sliva, D; Thyagarajan-Sahu, A	1

Other Studies

1 other study(ies) available for butyramide and Breast Neoplasms

Article	Year
NAHA, a novel hydroxamic acid-derivative, inhibits growth and angiogenesis of breast cancer in vitro and in vivo. PloS one, 2012, Volume: 7, Issue:3 Topics: Amides; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Humans; Hydroxamic Acids; In Vitro Techniques; Mice; Mice, Nude; Models, Chemical; Neoplasm Invasiveness; Neoplasm Transplantation; Oligonucleotide Array Sequence Analysis; Valine; Vascular Endothelial Growth Factor A	2012

Article

Year

NAHA, a novel hydroxamic acid-derivative, inhibits growth and angiogenesis of breast cancer in vitro and in vivo.

PloS one, 2012, Volume: 7, Issue:3

Topics: Amides; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Humans; Hydroxamic Acids; In Vitro Techniques; Mice; Mice, Nude; Models, Chemical; Neoplasm Invasiveness; Neoplasm Transplantation; Oligonucleotide Array Sequence Analysis; Valine; Vascular Endothelial Growth Factor A

2012